Navigation Links
Grifols and Talecris Biotherapeutics Announce the Signing of a Consent Agreement With FTC Staff
Date:5/2/2011

not limited to: the unprecedented volatility in the global economy; the risk that the future business operations of Talecris or Grifols will not be successful; the risk that we will not realize all of the anticipated benefits from the acquisition of Talecris; the risk that customer retention and revenue expansion goals for the Talecris transaction will not be met and that disruptions from the Talecris transaction will harm relationships with customers, employees and suppliers; the risk that unexpected costs will be incurred; the outcome of litigation and regulatory proceedings to which Grifols or Talecris may become a party; actions of competitors; changes and developments affecting our industry; quarterly or cyclical variations in financial results; development of new products and services; interest rates and cost of borrowing; our ability to protect our intellectual property rights; our ability to maintain and improve cost efficiency of operations, including savings from restructuring actions; changes in foreign currency exchange rates; changes in economic conditions, political conditions, trade protection measures, licensing requirements and tax matters in the foreign countries in which we do business; reliance on third parties for manufacturing of products and provision of services; and other factors that are set forth in the "Risk Factors" section, the "Management's Discussion and Analysis of Financial Condition and Results of Operations" section and other sections of and Talecris' Annual Report on Form 10-K for the year ended December 31, 2010, and its Quarterly Report on Form 10-Q for the quarter ended March 31, 2010 filed with the Securities and Exchange Commission.  Neither Grifols nor Talecris assume any obligation to update any forward-looking statements as a result of new information or future events or developments, except as required by law.  

The proposed merger transaction involving Grifols and Talecris will be submitted to the
'/>"/>

SOURCE Grifols, S.A.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Grifols Establishes Expert Advisory Council in Transfusion Medicine
2. Grifols Signs Cooperative Agreement for Commercialization of Immunohematology Diagnostic Products in the US
3. Grifols Starts Construction of a New Plasma Fractionation Plant in Barcelona (Parets Del Valles)
4. NASDAQ Removes TLCR From Biotechnology Index Pending FTC Decision on Grifols Acquisition
5. Health Robotics CytoCare Continues European Expansion With Grifols and Vall dHebron University Hospital
6. Grifols Agrees to Acquire Intellectual Property for Treatment of Post-Polio Syndrome From Pharmalink AB
7. AMDL Diagnostics, Inc. Enters Into Exclusive Distribution Agreement With Grifols USA, LLC to Advance Commercialization of DR-70 Onko-Sure(TM) Cancer Test
8. Health Robotics CytoCare(TM) Global Expansion Continues With Grifols International in Latin America
9. Alpha-1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics, Inc.
10. Talecris Biotherapeutics Enrolls Patients in Clinical Trial Evaluating Two Doses of PROLASTIN®-C
11. Talecris Biotherapeutics Launches PROLASTIN®-C in Canada
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... 2015 PTC Therapeutics, Inc. (NASDAQ: PTCT ... results for the second quarter ending June 30, 2015. ... across the organization.  We are excited to be near ... trial ever conducted with topline results expected in the ... Officer, PTC Therapeutics, Inc. "Translarna is now commercially available ...
(Date:7/30/2015)... 2015  Cleveland Clinic President Wael Barsoum , ... month that industry is compelled to adopt declining reimbursements ... efficiencies—and develop the transformational innovations -- required to thrive ... preceded by Doug Kohrs , past President and ... stressed that industry must add "episode of care," also ...
(Date:7/30/2015)... July 30, 2015 Future Market ... titled, "Continuous Glucose Monitoring Systems Market: Global Industry Analysis ... report, the global continuous glucose monitoring systems market was ... expected to reach US$ 788.4 Mn by 2020, registering ... to 2020. Global continuous glucose monitoring systems ...
Breaking Medicine Technology:PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 10Orthopaedic Surgery Reimbursement Shifts to Episode of Care 2Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 2Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 3Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 4
... issued the following update regarding the voluntary recall of AVEA® ... this action as a Class I recall. ... by the company and CareFusion is actively remediating the hardware ... parts manufactured between March 1, 2009 and June 30, 2011 ...
... Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... the company completed its previously announced acquisition of iNova, ... BofA Merrill Lynch and Baker & McKenzie ... About Valeant Pharmaceuticals International, Inc. ...
Cached Medicine Technology:CareFusion Provides Update on Previously Announced Ventilator Recall 2
(Date:7/31/2015)... ... 2015 , ... The 2015 New York Regional Conference on ... professionals, and researchers, covering a variety of topics related to mesothelioma and presented ... the Mesothelioma Applied Research Foundation and Memorial Sloan Kettering Cancer Center. , The ...
(Date:7/31/2015)... ... July 31, 2015 , ... “Engage: Don’t Just ... industry’s premier thought leadership symposiums, hosted by Massachusetts-based Harmony Healthcare International at ... attracts over 250 “C”-level executives, administrators, directors of nursing, rehabilitation managers and other ...
(Date:7/31/2015)... NY (PRWEB) , ... July 31, 2015 , ... The ... marijuana, on research projects that evaluate the potential of related, experimental treatments. The collaboration ... Department of Health to award Columbia Care one of five state licenses to produce ...
(Date:7/31/2015)... ... July 31, 2015 , ... Like nearly every other form of ... advanced, upgraded, made more effective and less intrusive and painful. Leading these advances ... Center. Dr. Loria currently stands as the only doctor in the United States ...
(Date:7/31/2015)... ... 31, 2015 , ... The Heart Fit Clinic has increased a patient's fitness ... rate of 150 beats versus 100 beats, this is a big deal," says Diamond ... life back to patients with heart disease," he adds. People with angina are able ...
Breaking Medicine News(10 mins):Health News:New York Area Mesothelioma Specialists to Present at Conference 2Health News:New York Area Mesothelioma Specialists to Present at Conference 3Health News:Harmony Healthcare International Announces Speaker Line-up for “HARMONY 2015” 2Health News:Harmony Healthcare International Announces Speaker Line-up for “HARMONY 2015” 3Health News:Mount Sinai to Collaborate with Columbia Care on Medical Marijuana Research 2Health News:Mount Sinai to Collaborate with Columbia Care on Medical Marijuana Research 3Health News:Loria Medical Penile Enlargement Center to Expand, Offering Practice Partnership to Doctors 2Health News:Heart Fit Clinic Helps Patient Increase Fitness Level with External Counterpulsation 2
... ... “Ten Best Staffing Firms to Work For,” published earlier this month in Staffing Industry ... ... research and analysts firm, surveys companies in the contingent staffing industry to determine the ...
... , WASHINGTON, Dec. 10 The following is ... Tobacco-Free Kids: , (Logo: http://www.newscom.com/cgi-bin/prnh/20080918/CFTFKLOGO ) , ... health and the public,s right to breathe clean air ... all restaurants and bars, smoke-free. Gov. Jennifer Granholm has ...
... tamoxifen can improve outcomes for postmenopausal breast cancer patients, according ... But a related study presented today at the 2009 San ... tumors can identify a subset of patients who may not ... Dr. Kathy Albain, of Loyola University Health System. Both ...
... ... Best Practices for Developing an Intelligent Portfolio , ... Austin, Texas (PRWEB) December 10, 2009 -- ... case study webinar discussing best practices for increasing the ROI of IT portfolios with ...
... well-resourced Global Fund for Education in 2010 will bring the world ... Dr. Paul Zeitz , WASHINGTON, Dec. 10 Today ... Universal Declaration of Human Rights which states (in Article 26): "Everyone ... least in the elementary and fundamental stages." , The ...
... DETROIT, Dec. 10 African-American political leaders, union members, ... 14th to create and implement a strategy to ... , "Detroit is leading the nation in murders, ... Horace Sheffield III, National Board Member and Michigan Chapter ...
Cached Medicine News:Health News:Jackson & Coker Ranks #3 among “Ten Best Staffing Firms to Work For” 2Health News:Jackson & Coker Ranks #3 among “Ten Best Staffing Firms to Work For” 3Health News:Jackson & Coker Ranks #3 among “Ten Best Staffing Firms to Work For” 4Health News:Approval of Michigan Smoke-Free Legislation is Historic Win for Health 2Health News:Approval of Michigan Smoke-Free Legislation is Historic Win for Health 3Health News:Definitive study confirms chemo benefit in postmenopausal breast cancer 2Health News:Definitive study confirms chemo benefit in postmenopausal breast cancer 3Health News:Planview and Carestream Health Discuss the Intelligent Portfolio on December 17 Webinar 2Health News:Planview and Carestream Health Discuss the Intelligent Portfolio on December 17 Webinar 3Health News:Human Rights Denied: Obama Leaves 75 Million Children Behind 2Health News:Black Community Unites Against HIV/AIDS Epidemic 2
Freer elevator, double end, 7 1/4", S/B....
... The Surgifoam* absorbable gelatin sponge, U.S.P. ... gelatin absorbable sponge intended for hemostatic ... surface. The sponge is off-white and ... speed to hemostasis, highly favorable surgeon ...
... absorbable gelatin sponge, U.S.P. is a ... sponge intended for hemostatic use by ... sponge is off-white and porous in ... hemostasis, highly favorable surgeon preference ratings ...
16 mm diameter curved probes with suture eyes just back of blunt ends. Stainless steel. Round knurled handle with polished finish. Overall length: 5.7 inches....
Medicine Products: